| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |